Abstract
RGD-PEG-BaGdF5 NPs can be used as CT/MR dual-modality contrast agents of solid tumors via the RGD-mediated tumor vasculature targeting strategy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
